mannitol has been researched along with isoniazid in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (33.33) | 29.6817 |
| 2010's | 6 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Campillo, NE; Guerra, A; Páez, JA | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Barroso, EC; Bushen, OY; Façanha, MC; Guerrant, RL; Lima, AA; Monteiro, HS; Peloquin, CA; Pinheiro, VG; Ramos, LM | 1 |
| Gokhale, YA; Mehta, AD; Rathod, NN; Vaidya, MS | 1 |
| Momose, Y; Takehira, R; Yamamura, S | 1 |
| Ho, SC; Hsiong, CH; Hu, OY; Huang, TY; Shih, TY | 1 |
1 review(s) available for mannitol and isoniazid
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for mannitol and isoniazid
| Article | Year |
|---|---|
Selected pharmaceutical excipient prevent isoniazid and rifampicin induced hepatotoxicity.
Topics: Adult; Animals; Antitubercular Agents; Chemical and Drug Induced Liver Injury; Cytochrome P-450 CYP2E1 Inhibitors; Drug Combinations; Excipients; Female; Humans; Isoniazid; Male; Mannitol; Mice; Mice, Inbred Strains; Microsomes, Liver; Middle Aged; Mycobacterium tuberculosis; Rats; Rats, Sprague-Dawley; Rifampin; Young Adult | 2013 |
7 other study(ies) available for mannitol and isoniazid
| Article | Year |
|---|---|
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Intestinal permeability and malabsorption of rifampin and isoniazid in active pulmonary tuberculosis.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Case-Control Studies; Chromatography, High Pressure Liquid; Cross-Sectional Studies; Female; Humans; Intestinal Absorption; Isoniazid; Lactulose; Male; Mannitol; Middle Aged; Permeability; Rifampin; Tuberculosis, Pulmonary | 2006 |
Isoniazid toxicity presenting as status epilepticus and severe metabolic acidosis.
Topics: Acidosis; Adult; Antitubercular Agents; Bicarbonates; Buffers; Diuretics, Osmotic; Female; Humans; Isoniazid; Mannitol; Pyridoxine; Status Epilepticus; Vitamin B Complex | 2009 |
Quantitative analysis of crystalline pharmaceuticals in tablets by pattern-fitting procedure using X-ray diffraction pattern.
Topics: Crystallization; Isoniazid; Mannitol; Tablets; X-Ray Diffraction | 2010 |